Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index; 13 of the 19 sources its claims cite were checked for support.

Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy

Open access
Giordano, Giulia, Colaneri, Marta, Di Filippo, Alessandro, Blanchini, Franco, Bolzern, Paolo, De Nicolao, Giuseppe, Sacchi, Paolo, Colaneri, Patrizio, Bruno, Raffaele · 2021 · Nature Medicine

Published version of a preprint

Abstract

Despite progress in clinical care for patients with coronavirus disease 2019 (COVID-19) 1 , population-wide interventions are still crucial to manage the pandemic, which has been aggravated by the emergence of new, highly transmissible variants. In this study, we combined the SIDARTHE model 2 , which predicts the spread of SARS-CoV-2 infections, with a new data-based model that projects new cases onto casualties and healthcare system costs. Based on the Italian case study, we outline several scenarios: mass vaccination campaigns with different paces, different transmission rates due to new variants and different enforced countermeasures, including the alternation of opening and closure phases. Our results demonstrate that non-pharmaceutical interventions (NPIs) have a higher effect on the epidemic evolution than vaccination alone, advocating for the need to keep NPIs in place during the first phase of the vaccination campaign. Our model predicts that, from April 2021 to January 2022, in a scenario with no vaccine rollout and weak NPIs ( $${\cal{R}}_0$$ R 0 = 1.27), as many as 298,000 deaths associated with COVID-19 could occur. However, fast vaccination rollouts could reduce mortality to as few as 51,000 deaths. Implementation of restrictive NPIs ( $${\cal{R}}_0$$ R 0 = 0.9) could reduce COVID-19 deaths to 30,000 without vaccinating the population and to 18,000 with a fast rollout of vaccines. We also show that, if intermittent open–close strategies are adopted, implementing a closing phase first could reduce deaths (from 47,000 to 27,000 with slow vaccine rollout) and healthcare system costs, without substantive aggravation of socioeconomic losses.

Overview

CoChat Summary

## TL;DR

The paper combines a compartmental epidemic model (SIDARTHE-V) with a data-based healthcare-cost model to evaluate how vaccination speed, SARS-CoV-2 variants, and non-pharmaceutical interventions (NPIs) affect COVID-19 outcomes in Italy. It concludes that NPIs have a larger impact than vaccination speed alone, especially early in the vaccination campaign.

## Key findings

  • In the main scenarios, deaths from April 2021 to January 2022 ranged from 30,000 to 298,000 with no vaccination rollout, 20,000 to 91,000 with slow vaccination, 19,000 to 72,000 with medium vaccination, and 18,000 to 51,000 with fast vaccination.
  • Under a scenario with weak restrictions and no vaccination, the model projects as many as 298,000 deaths; with restrictive NPIs (\(= 0.9\)), deaths could be reduced to 30,000 without vaccination and 18,000 with fast vaccination.
  • If intermittent open–close strategies are used, starting with a closing phase instead of an opening phase could reduce deaths from 47,000 to 27,000 with slow vaccine rollout, without substantive worsening of socioeconomic losses.
  • With medium vaccination speed and higher transmissibility from variants, the model predicts within 2 months a peak of almost 4,000 ICU beds needed and more than 700 daily deaths unless NPIs are strengthened.

## Methods

  • The study combines two linked models: SIDARTHE-V, a compartmental model extended to include vaccination, and a data-driven model that maps predicted new cases to deaths, hospital occupancy, and ICU occupancy.
  • Parameters for the epidemic model were fit to official Italian data from 24 February 2020 through 26 March 2021; the healthcare-cost model used second-wave data in a 110-day window ending 7 February 2021, plus age and demographic data from Italian public repositories.
  • The authors simulated 20 scenarios from the combination of 4 vaccination schedules (absent, slow, medium, fast; reaching 0%, 47%, 64%, 90% immunized by January 2022) and 5 transmission/restriction profiles.

## Limitations

  • The paper states that SIDARTHE-V is a mean-field compartmental model assuming homogeneous mixing, so it does not account for geographical heterogeneity; the text suggests more detailed spatial/social-network models could be used instead.
  • The authors note they assumed vaccination is effective against SARS-CoV-2 variants, even though immune escape was a concern; this is a stated limitation.
  • They also optimistically assumed protection against death and hospitalization starts 3 weeks after the first dose rather than after the second dose; this is stated as an assumption and may limit realism.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41591-021-01334-5

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Model scheme and summary of our findings. a, Graphical scheme of our model (adapted from Giordano et al.2). The compartmental SIDARTHE-V epidemiological model provides daily new cases as an input to a novel data-based model of casualties and healthcare system costs. The SIDARTHE-V model captures the dynamic interactions among nine mutually exclusive infection stages in the population: S, Susceptible (uninfected); I, Infected (asymptomatic infected, undetected); D, Diagnosed (asymptomatic infected, detected); A, Ailing (symptomatic infected, undetected); R, Recognized (symptomatic infected, detected); T, Threatened (infected with life-threatening symptoms, detected); H, Healed (recovered); E, Extinct (dead); and V, Vaccinated (successfully immunized). The SIDARTHE-V model provides the time evolution of daily new infection cases, based on which the data-driven model computes the evolution of deaths and ICU and hospital occupancy. b, Death versus vaccination speed curves. For a given R0 profile, the curve gives the death toll in the period from April 2021 to January 2022 as a function of the average vaccination speed, measured as the fraction of vaccinated population at the end of the period. The death versus vaccination speed curves corresponding to a constant reproduction number are reported in purple (R0=1.27), orange (R0=1.1) and blue (R0=0.9), whereas those corresponding to intermittent strategies are reported in red (Open–Close) and green (Close–Open).
Fig. 1 Model scheme and summary of our findings. a, Graphical scheme of our model (adapted from Giordano et al.2). The compartmental SIDARTHE-V epidemiological model provides daily new cases as an input to a novel data-based model of casualties and healthcare system costs. The SIDARTHE-V model captures the dynamic interactions among nine mutually exclusive infection stages in the population: S, Susceptible (uninfected); I, Infected (asymptomatic infected, undetected); D, Diagnosed (asymptomatic infected, detected); A, Ailing (symptomatic infected, undetected); R, Recognized (symptomatic infected, detected); T, Threatened (infected with life-threatening symptoms, detected); H, Healed (recovered); E, Extinct (dead); and V, Vaccinated (successfully immunized). The SIDARTHE-V model provides the time evolution of daily new infection cases, based on which the data-driven model computes the evolution of deaths and ICU and hospital occupancy. b, Death versus vaccination speed curves. For a given R0 profile, the curve gives the death toll in the period from April 2021 to January 2022 as a function of the average vaccination speed, measured as the fraction of vaccinated population at the end of the period. The death versus vaccination speed curves corresponding to a constant reproduction number are reported in purple (R0=1.27), orange (R0=1.1) and blue (R0=0.9), whereas those corresponding to intermittent strategies are reported in red (Open–Close) and green (Close–Open).CC BY · PubMed Central
Fig. 2 The effect of different constant values of R0 and intermittent strategies. Time evolution of the epidemic, in the presence of medium-speed vaccination (64% of the population vaccinated within January 2022), when: a–f, different constant values of R0, namely R0=1.27 (purple), R0=1.1 (orange) and R0=0.9 (blue), are assumed, resulting from different variants and/or containment strategies, and when: g–l, two alternative intermittent strategies are enforced, with an average value of R0 equal to 1.1. The Open–Close strategy (red) switches every month between R0=1.27 and R0=0.9 starting with R0=1.27. The Close–Open strategy (green) switches every month between R0=0.9 and R0=1.27 starting with R0=0.9. a,g, Time evolution of the fractions of susceptibles, vaccinated, infected and recovered, and dead. b,h, Daily new cases. c,i, Active cases. d,j, Hospital occupancy. e,k, ICU occupancy. f,l, Daily deaths.
Fig. 2 The effect of different constant values of R0 and intermittent strategies. Time evolution of the epidemic, in the presence of medium-speed vaccination (64% of the population vaccinated within January 2022), when: a–f, different constant values of R0, namely R0=1.27 (purple), R0=1.1 (orange) and R0=0.9 (blue), are assumed, resulting from different variants and/or containment strategies, and when: g–l, two alternative intermittent strategies are enforced, with an average value of R0 equal to 1.1. The Open–Close strategy (red) switches every month between R0=1.27 and R0=0.9 starting with R0=1.27. The Close–Open strategy (green) switches every month between R0=0.9 and R0=1.27 starting with R0=0.9. a,g, Time evolution of the fractions of susceptibles, vaccinated, infected and recovered, and dead. b,h, Daily new cases. c,i, Active cases. d,j, Hospital occupancy. e,k, ICU occupancy. f,l, Daily deaths.CC BY · PubMed Central
Fig. 3 The effect of different vaccination paces. Time evolution of the epidemic, with an intermittent Open–Close strategy enforced, in the presence of slow vaccination (47% of the population vaccinated within January 2022, red) or fast vaccination (90% of the population vaccinated within January 2022, blue). a, Time evolution of the fractions of susceptible, vaccinated, infected and recovered, and dead. b, Daily new cases. c, Active cases. d, Hospital occupancy. e, ICU occupancy. f, Daily deaths.
Fig. 3 The effect of different vaccination paces. Time evolution of the epidemic, with an intermittent Open–Close strategy enforced, in the presence of slow vaccination (47% of the population vaccinated within January 2022, red) or fast vaccination (90% of the population vaccinated within January 2022, blue). a, Time evolution of the fractions of susceptible, vaccinated, infected and recovered, and dead. b, Daily new cases. c, Active cases. d, Hospital occupancy. e, ICU occupancy. f, Daily deaths.CC BY · PubMed Central
Extended Data Fig. 1 Epidemic evolution in Italy from late February 2020 to March 2021. Data (stars) and estimation (solid lines), based on the SIDARTHE model, of the time evolution of the epidemic, in logarithmic scale. Active cases (current diagnosed infected, related to the SIDARTHE variables R+T+D) are shown in orange; hospital occupancy (related to the SIDARTHE variables R+T) is shown in blue; ICU occupancy (related to variable T) is shown in magenta; daily deaths (related to the derivative of variable E) are shown in black.
Extended Data Fig. 1 Epidemic evolution in Italy from late February 2020 to March 2021. Data (stars) and estimation (solid lines), based on the SIDARTHE model, of the time evolution of the epidemic, in logarithmic scale. Active cases (current diagnosed infected, related to the SIDARTHE variables R+T+D) are shown in orange; hospital occupancy (related to the SIDARTHE variables R+T) is shown in blue; ICU occupancy (related to variable T) is shown in magenta; daily deaths (related to the derivative of variable E) are shown in black.CC BY · PubMed Central
Extended Data Fig. 2 Epidemic evolution without vaccination for different constant values of R0. Time evolution of the epidemic, in the absence of vaccination, when different constant values of R0, namely R0=1.27 (purple), R0=1.1 (orange), R0=0.9 (blue), are assumed, resulting from different variants and/or containment strategies. a, Time evolution of the fractions of susceptibles, infected and recovered, and dead. b, Daily new cases. c, Active cases. d, Hospital occupancy. e, ICU occupancy. f, Daily deaths.
Extended Data Fig. 2 Epidemic evolution without vaccination for different constant values of R0. Time evolution of the epidemic, in the absence of vaccination, when different constant values of R0, namely R0=1.27 (purple), R0=1.1 (orange), R0=0.9 (blue), are assumed, resulting from different variants and/or containment strategies. a, Time evolution of the fractions of susceptibles, infected and recovered, and dead. b, Daily new cases. c, Active cases. d, Hospital occupancy. e, ICU occupancy. f, Daily deaths.CC BY · PubMed Central
Extended Data Fig. 3 Epidemic evolution without vaccination for different intermittent strategies. Time evolution of the epidemic, in the absence of vaccination, when two alternative intermittent strategies are enforced, with an average value of R0 equal to 1.1. The Open-Close strategy (red) switches every month between R0=1.27 and R0=0.9, starting with R0=1.27. The Close-Open strategy (green) does the same, but starts with R0=0.9. a, Time evolution of the fractions of susceptibles, infected and recovered, and dead. b, Daily new cases. c, Active cases. d, Hospital occupancy. e, ICU occupancy. f, Daily deaths.
Extended Data Fig. 3 Epidemic evolution without vaccination for different intermittent strategies. Time evolution of the epidemic, in the absence of vaccination, when two alternative intermittent strategies are enforced, with an average value of R0 equal to 1.1. The Open-Close strategy (red) switches every month between R0=1.27 and R0=0.9, starting with R0=1.27. The Close-Open strategy (green) does the same, but starts with R0=0.9. a, Time evolution of the fractions of susceptibles, infected and recovered, and dead. b, Daily new cases. c, Active cases. d, Hospital occupancy. e, ICU occupancy. f, Daily deaths.CC BY · PubMed Central
Extended Data Fig. 4 Effective vaccination schedules. Profiles of the considered three different effective vaccination schedules: slow, medium and fast. For each of the three schedules, we show: the evolution over time of the daily effective vaccination rate, namely the fraction of population successfully immunised (second dose) in one day (a-d-g), the cumulative fraction of immunised population as a function of time (b-e-h), the resulting time-varying Case Fatality Rate as a function of time, obtained taking population age classes into account and assuming a vaccination schedule that prioritises the elderly (c-f-i).
Extended Data Fig. 4 Effective vaccination schedules. Profiles of the considered three different effective vaccination schedules: slow, medium and fast. For each of the three schedules, we show: the evolution over time of the daily effective vaccination rate, namely the fraction of population successfully immunised (second dose) in one day (a-d-g), the cumulative fraction of immunised population as a function of time (b-e-h), the resulting time-varying Case Fatality Rate as a function of time, obtained taking population age classes into account and assuming a vaccination schedule that prioritises the elderly (c-f-i).CC BY · PubMed Central
Extended Data Fig. 5 Time-varying age-dependent Case Fatality Rate as a function of the vaccination schedule. Computation of the time-varying Case Fatality Rate as a function of the vaccination roadmap, taking population age classes into account. a, Considered vaccination roadmap: fraction of non-vaccinated population over time. b, Cumulative Italian population as a function of age. c, Fraction of the population (red) and Case Fatality Rate (purple) as a function of age. d, Evolution of the overall Case Fatality Rate over time, assuming a vaccination schedule that gives priority to the elderly.
Extended Data Fig. 5 Time-varying age-dependent Case Fatality Rate as a function of the vaccination schedule. Computation of the time-varying Case Fatality Rate as a function of the vaccination roadmap, taking population age classes into account. a, Considered vaccination roadmap: fraction of non-vaccinated population over time. b, Cumulative Italian population as a function of age. c, Fraction of the population (red) and Case Fatality Rate (purple) as a function of age. d, Evolution of the overall Case Fatality Rate over time, assuming a vaccination schedule that gives priority to the elderly.CC BY · PubMed Central
Extended Data Fig. 6 Epidemic evolution with adaptive vaccination for different constant values of R0. Time evolution of the epidemic, with adaptive vaccination, when different constant values of R0, namely R0=1.27 (purple), R0=1.1 (orange), R0=0.9 (blue), are assumed, associated with different variants and/or containment strategies. The adaptive vaccination speed is inversely proportional to the size of the epidemic, that is to the number of infection cases. a, Time evolution of the fractions of susceptibles, vaccinated, infected and recovered, and dead. b, Daily new cases. c, Active cases. d, Hospital occupancy. e, ICU occupancy. f, Daily deaths.
Extended Data Fig. 6 Epidemic evolution with adaptive vaccination for different constant values of R0. Time evolution of the epidemic, with adaptive vaccination, when different constant values of R0, namely R0=1.27 (purple), R0=1.1 (orange), R0=0.9 (blue), are assumed, associated with different variants and/or containment strategies. The adaptive vaccination speed is inversely proportional to the size of the epidemic, that is to the number of infection cases. a, Time evolution of the fractions of susceptibles, vaccinated, infected and recovered, and dead. b, Daily new cases. c, Active cases. d, Hospital occupancy. e, ICU occupancy. f, Daily deaths.CC BY · PubMed Central
Extended Data Fig. 7 Epidemic evolution with adaptive vaccination for different intermittent strategies. Time evolution of the epidemic, with adaptive vaccination, when different intermittent strategies are enforced, with an average value of R0 equal to 1.1. The Open-Close strategy (red) switches every month between R0=1.27 and R0=0.9, starting with R0=1.27. The Close-Open strategy (green) does the same, but starts with R0=0.9. The adaptive vaccination speed is inversely proportional to the size of the epidemic, that is to the number of infection cases. a, Time evolution of the fractions of susceptibles, vaccinated, infected and recovered, and dead. b, Daily new cases. c, Active cases. d, Hospital occupancy. e, ICU occupancy. f, Daily deaths.
Extended Data Fig. 7 Epidemic evolution with adaptive vaccination for different intermittent strategies. Time evolution of the epidemic, with adaptive vaccination, when different intermittent strategies are enforced, with an average value of R0 equal to 1.1. The Open-Close strategy (red) switches every month between R0=1.27 and R0=0.9, starting with R0=1.27. The Close-Open strategy (green) does the same, but starts with R0=0.9. The adaptive vaccination speed is inversely proportional to the size of the epidemic, that is to the number of infection cases. a, Time evolution of the fractions of susceptibles, vaccinated, infected and recovered, and dead. b, Daily new cases. c, Active cases. d, Hospital occupancy. e, ICU occupancy. f, Daily deaths.CC BY · PubMed Central
Extended Data Fig. 8 Health costs as a function of vaccination speed. Health-cost vs. vaccination-speed curves: for a given R0 profile, the curve gives the total ICU occupancy (a) and the total hospital occupancy (b) in the period from April 2021 to January 2022, as a function of the average vaccination speed, measured as the fraction of two-dose vaccinated population at the end of the period. The health-cost vs. vaccination-speed curves corresponding to a constant reproduction number are reported in purple (R0=1.27), orange (R0=1.1) and blue (R0=0.9), while those corresponding to intermittent strategies are reported in red (Open-Close) and green (Close-Open).
Extended Data Fig. 8 Health costs as a function of vaccination speed. Health-cost vs. vaccination-speed curves: for a given R0 profile, the curve gives the total ICU occupancy (a) and the total hospital occupancy (b) in the period from April 2021 to January 2022, as a function of the average vaccination speed, measured as the fraction of two-dose vaccinated population at the end of the period. The health-cost vs. vaccination-speed curves corresponding to a constant reproduction number are reported in purple (R0=1.27), orange (R0=1.1) and blue (R0=0.9), while those corresponding to intermittent strategies are reported in red (Open-Close) and green (Close-Open).CC BY · PubMed Central
Extended Data Fig. 9 Dynamic input-output models for health costs. Estimation of the three dynamic input-output models linking new cases (input) to three outputs: deaths (a), hospital occupancy (b) and ICU occupancy (c). Each panel displays the observed outputs (grey) and the values predicted by the identified dynamic system (blue). In order to allow for weekly oscillations both input and output series were prefiltered with a 7-day moving average before performing nonlinear least squares fitting of a first-order model with delay. The FIT ratios of the three models are 83.16%, 84.67%, and 87.53%.
Extended Data Fig. 9 Dynamic input-output models for health costs. Estimation of the three dynamic input-output models linking new cases (input) to three outputs: deaths (a), hospital occupancy (b) and ICU occupancy (c). Each panel displays the observed outputs (grey) and the values predicted by the identified dynamic system (blue). In order to allow for weekly oscillations both input and output series were prefiltered with a 7-day moving average before performing nonlinear least squares fitting of a first-order model with delay. The FIT ratios of the three models are 83.16%, 84.67%, and 87.53%.CC BY · PubMed Central

Verification

Claims the paper makes

9 Valid · 4 Not valid · 3 Not checked · 61 Own results and interpretations

29 more claims

Create a free account to see all 77 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 32
  • Probably not a substantial claim. 13
  • The quote only partly states this claim. 3

Create a free account to see these claims.

Citations

Cites

Show all 44 references

Cited by

See all 192

Metadata

Authors
Giordano, G., Colaneri, M., Di Filippo, A., Blanchini, F., Bolzern, P., De Nicolao, G., Sacchi, P., Colaneri, P., & Bruno, R.
Affiliations
  • University of Trento (IT)
  • Policlinico San Matteo Fondazione (IT)
  • University of Udine (IT)
  • Politecnico di Milano (IT)
  • Institute of Electronics, Computer and Telecommunication Engineering (IT)
  • University of Pavia (IT)
Corresponding author
Giordano, Giulia
Venue
Nature Medicine
Published
2021-04-16
Volume
27
Issue
6
Pages
993-998
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W3155313092
Cited by
192
References
44
Citations by year
2026: 2 · 2025: 13 · 2024: 15 · 2023: 36 · 2022: 79 · 2021: 46
FWCI
16.98
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Medicine (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • arXiv (Cornell University) (submittedVersion)
  • Iris (University of Trento) (submittedVersion, cc-by)
  • Virtual Community of Pathological Anatomy (University of Castilla La Mancha) (submittedVersion, other-oa)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
  • Institutional Research Information System (University of Udine) (submittedVersion, cc-by-nc-nd)
  • arXiv (Cornell University)
Funders
  • European Commission (H2020 SC1, PRIN 2017, SC1-PHE-CORONAVIRUS-2020, H2020-SC1-PHE-CORONAVIRUS-2020-2-RTD, HORIZON2020, H2020, 101016233)
  • Horizon 2020 Framework Programme (H2020-SC1-PHE CORONAVIRUS-2020-2-RTD, 101016233, H2020-SC1, 101016233, H2020-SC1-PHE CORONAVIRUS-2020-2-RTD)
Topics
  • Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Physical Sciences › Mathematics › Applied Mathematics › Mathematical and Theoretical Epidemiology and Ecology Models
Keywords
COVID-19 pandemic, SARS-CoV-2 variants, vaccine rollout, non-pharmaceutical interventions, epidemic modeling, COVID-19 mortality, basic reproduction number, Italy
MeSH terms
COVID-19, SARS-CoV-2, COVID-19 Vaccines, Humans, Italy, Vaccination, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy. https://app.cochat.ai/papers/10.1038/s41591-021-01334-5
The paper
Giordano, G., Colaneri, M., Di Filippo, A., Blanchini, F., Bolzern, P., De Nicolao, G., Sacchi, P., Colaneri, P., & Bruno, R. (2021). Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy. Nature Medicine. https://doi.org/10.1038/s41591-021-01334-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.